Product Information
ARIPIPRAZOLE 1 MG/ML SOLUTION is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.3312 per ML under NDC 31722068415. Its NADAC has been published 126 times since May 8, 2024.
FDA first approved this application on Nov 1, 2023. Its Orange Book therapeutic-equivalence code is AA.
Strength
1 mg/mL
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722068415
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ARIPIPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA216150FDA Approved
11/1/2023
TE Code
AA
On Market Since
11/1/2023
Pharmacological Classes
Price Statistics
The NADAC for ARIPIPRAZOLE 1 MG/ML SOLUTION has been published 126 times since May 8, 2024, and over the history we have for it it has declined 37.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3312 per ML |
|---|---|
| All-time high | $0.7409 (Jul 10, 2024) |
| All-time low | $0.3131 (Aug 19, 2026) |
| 52-week high | $0.5159 |
| 52-week low | $0.3131 |
| Median price | $0.4849 |
| Average price | $0.4716 |
| Largest weekly change | -44.9% (Jul 17, 2024) |
| Weeks tracked | 126 |
| Tracking since | May 8, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Aripiprazole oral market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARIPIPRAZOLE 1 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for ARIPIPRAZOLE 1 MG/ML SOLUTION, manufactured by Camber Pharmaceuticals Inc., is $0.3312 per ML (NDC 31722068415), effective Sep 30, 2026.
How has the price of ARIPIPRAZOLE 1 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for ARIPIPRAZOLE 1 MG/ML SOLUTION has declined 37.4%. It has been tracked across 126 weekly CMS publications since May 8, 2024.
What are the highest and lowest recorded NADAC prices for ARIPIPRAZOLE 1 MG/ML SOLUTION?
Since May 8, 2024, the NADAC for ARIPIPRAZOLE 1 MG/ML SOLUTION has ranged from a low of $0.3131 (Aug 19, 2026) to a high of $0.7409 (Jul 10, 2024), with a median of $0.4849 per ML.
Are there cheaper alternatives to ARIPIPRAZOLE 1 MG/ML SOLUTION?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ARIPIPRAZOLE 1 MG/ML SOLUTION in a comparable dosage form, but none are currently priced below it.
Who manufactures ARIPIPRAZOLE 1 MG/ML SOLUTION?
ARIPIPRAZOLE 1 MG/ML SOLUTION (NDC 31722068415) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.